ZARA, Gian Paolo
 Distribuzione geografica
Continente #
NA - Nord America 6.081
AS - Asia 3.504
EU - Europa 3.267
SA - Sud America 452
AF - Africa 97
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 10
Totale 13.433
Nazione #
US - Stati Uniti d'America 5.956
SG - Singapore 1.364
CN - Cina 1.185
IT - Italia 581
IE - Irlanda 443
SE - Svezia 407
BR - Brasile 382
DE - Germania 381
UA - Ucraina 308
FI - Finlandia 281
FR - Francia 275
KR - Corea 269
VN - Vietnam 193
GB - Regno Unito 165
IN - India 159
AT - Austria 140
PL - Polonia 113
CA - Canada 92
ID - Indonesia 44
RU - Federazione Russa 42
JP - Giappone 41
SN - Senegal 38
BE - Belgio 36
IR - Iran 33
AR - Argentina 32
TR - Turchia 31
HK - Hong Kong 29
NL - Olanda 24
PK - Pakistan 24
MX - Messico 23
IQ - Iraq 22
ZA - Sudafrica 20
AU - Australia 19
BD - Bangladesh 17
TH - Thailandia 15
JO - Giordania 14
EG - Egitto 13
ES - Italia 13
UZ - Uzbekistan 10
CH - Svizzera 9
BY - Bielorussia 8
MU - Mauritius 8
PT - Portogallo 8
EU - Europa 7
PY - Paraguay 7
RO - Romania 7
CO - Colombia 6
EC - Ecuador 6
IL - Israele 6
MY - Malesia 6
AE - Emirati Arabi Uniti 5
DK - Danimarca 5
LT - Lituania 5
MA - Marocco 5
PE - Perù 5
PS - Palestinian Territory 5
TW - Taiwan 5
VE - Venezuela 5
CL - Cile 4
PA - Panama 4
AZ - Azerbaigian 3
CZ - Repubblica Ceca 3
KE - Kenya 3
OM - Oman 3
PH - Filippine 3
TJ - Tagikistan 3
TN - Tunisia 3
UY - Uruguay 3
AP - ???statistics.table.value.countryCode.AP??? 2
BO - Bolivia 2
DZ - Algeria 2
GR - Grecia 2
MK - Macedonia 2
NZ - Nuova Zelanda 2
RS - Serbia 2
SA - Arabia Saudita 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BT - Bhutan 1
BW - Botswana 1
CR - Costa Rica 1
CU - Cuba 1
DJ - Gibuti 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GI - Gibilterra 1
HN - Honduras 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MO - Macao, regione amministrativa speciale della Cina 1
NG - Nigeria 1
NI - Nicaragua 1
Totale 13.424
Città #
Beijing 776
Chandler 705
Singapore 697
Ashburn 448
Dublin 443
Santa Clara 384
Dallas 316
Jacksonville 253
Fairfield 243
Torino 243
Ann Arbor 242
Houston 215
Woodbridge 147
Medford 144
Nyköping 142
Villeurbanne 135
Vienna 132
Wilmington 129
Princeton 127
Columbus 121
Dearborn 110
Warsaw 109
Seattle 94
Los Angeles 81
Buffalo 78
Pisa 77
Cambridge 70
Munich 64
Milan 57
Fremont 55
Dong Ket 52
Seoul 51
Hefei 50
Boston 46
Washington 46
Ho Chi Minh City 43
Toronto 42
Redwood City 41
Boardman 37
The Dalles 35
Shanghai 34
São Paulo 34
Verona 33
Brussels 32
Jakarta 31
Hanoi 30
Nanjing 29
New York 27
Guangzhou 26
Pune 26
Hong Kong 25
Ottawa 22
Turku 21
Falls Church 20
Norwalk 19
Frankfurt am Main 16
Helsinki 16
Rio de Janeiro 15
Nuremberg 14
Bengaluru 12
Mumbai 12
Zhengzhou 12
Bangkok 11
Chennai 11
Hyderabad 11
London 11
Chicago 10
Monmouth Junction 10
Phoenix 10
Tokyo 10
Chengdu 9
Kunming 9
Lachine 9
Wuhan 9
Brooklyn 8
Hangzhou 8
Jinan 8
Johannesburg 8
Melbourne 8
Mountain View 8
Shenyang 8
Ankara 7
Brasília 7
Curitiba 7
Falkenstein 7
Fuzhou 7
Kansas City 7
Karachi 7
Mexico City 7
Osasco 7
Redondo Beach 7
San Diego 7
Amman 6
Baghdad 6
Cagliari 6
Changsha 6
Chongqing 6
Coimbatore 6
Detroit 6
Islamabad 6
Totale 8.087
Nome #
GSH-targeted nanosponges increase doxorubicin-induced toxicity "in vitro" and "in vivo" in cancer cells with high antioxidant defenses 384
Solid lipid nanoparticles as promising tool for intraocular tobramycin delivery: Pharmacokinetic studies on rabbits 372
Characterization of biological features of a rat F98 GBM model: a PET-MRI study with [18F]FAZA and [18F]FDG 346
Solid lipid nanoparticles and microemulsions for drug delivery The CNS. 288
Drug Delivery Nanoparticles in Skin Cancers 264
Cholesteryl butyrate solid lipid nanoparticles inhibit the adhesion and migration of colon cancer cells. 251
5-Fluorouracile loaded beta-ctclodextrin nanosponges: in vitro characterisation and cytotoxicity 248
Solid lipid nanoparticles of cholesteryl butyrate inhibit the proliferation of cancer cells in vitro and in vivo models. 236
High energy shock waves and 5-aminolevulinic for sonodynamic therapy: effects in a syngeneic model of colon cancer 211
Cytotoxicity of anticancer drugs incorporated in solid lipid nanoparticles on HT-29 colorectal cancer cell line 169
Cholesteryl butyrate solid lipid nanoparticles inhibit adhesion and migration of colon cancer cells 164
Determination of disodium clodronate in human plasma and urine using gas-chromatography-nitrogen-phosphorous detection: validation and application in pharmacokinetic study 162
Solid lipid nanoparticles for brain tumors therapy: State of the art and novel challenges 155
Antibiotic dosage individualization through Bayesian inference on PK-PD population data 154
Baclofen-loaded solid lipid nanoparticles: Preparation, electrophysiological assessment of efficacy, pharmacokinetic and tissue distribution in rats after intraperitoneal administration 154
Application of pharmacoeconomics to the use of antibiotics. 151
A new apomorphine formulation for oral administration 151
Plasma concentrations of 5-fluorouracil and its metabolites in colon cancer patients 150
Modulation of butyrate anticancer activity by solid lipid nanoparticle delivery: an in vitro investigation on human breast cancer and leukemia cell lines 150
Accumulation and cytotoxic activity of different doxorubicin formulations in human cancer cell lines 148
Accumulation and cytotoxic activity of different doxorubicin formulations in human cancer cell lines 144
Innovative formulations for the controlled and site-specific delivery of antiinflammatory drugs 142
Insulin-Loaded SLN Prepared with the Emulsion Dilution Technique: In Vivo Tracking of Nanoparticles after Oral Administration to Rats 141
Analysis of thiopurine-methyl-transferase (TPMT) genotype and phenotype in a northern Italian population 136
Azione citotossica in vitro del colesterilbutirrato incorporato in nanoparticelle lipidiche solide 135
Pharmacokinetics of doxorubicin incorporated in solid lipid nanospheres (SLN). 134
Solid lipid nanoparticles formed by solvent-in-water emulsion diffusion tecnique: development and influence of insulin stability 134
Different approaches in SLN formulation for cancer therapy 132
Solid lipid nanoparticles as anti-inflammatory drug delivery system in a human inflammatory bowel disease whole blood model 132
Cytotoxicity of solid lipid nanoparticles incorporating butyric acid and doxorubicin on a human colorectal cancer cell line 131
Solid lipid nanoparticles in lymph and plasma after duodenal administration to rats. 130
Application of Parzaen-based probabilistic neural networks to predict individual plasma concentration from population data 130
A Non-Parametric Population PK/PD Analysis Of Tolcapone To Predict L-Dopa Plasma Concentrations 130
Cholesteryl butyrate solid lipid nanoparticles as a butyric acid pro-drug: effects on cell proliferation, cell-cycle distribution and c-myc expression in human leukemic cells 130
Transmucosal transport of tobramycin incorporated in SLN after duodenal administration to rats. Part I--a pharmacokinetic study. 128
Analgesic effect of bisphosphonates in mice. 126
Transmucosal transport of tobramycin incorporated in solid lipid nanoparticles (SLN) after duodenal administration to rats. Part II--tissue distribution. 124
Plasma Erythropoietin levels in patients receiving intensive platinum or non-platinum chemotherapy 124
5-Aminolevulinic Acid and High Energy Shock Waves for Sonodynamic Therapy: Effects on SK-N-BE and SH-SY5Y Neuroblastoma Cell Lines 120
High Energy Shock Waves (HESW) for Sonodynamic Therapy: Effects on HT-29 Human Colon Cancer Cells 118
Aminosalycilates do not affect thiopurine-methyl-transferase (TPMT) activity in inflammatory bowel disease (IBD) 118
Enhanced oral bioavailability of resveratrol using lipid formulations 118
HPLC determination of 5-FU and three metabolites in the plasma of cancer patients 117
5-Aminolevulinic Acid and High Energy Shock Waves for Sonodynamic Therapy: effects on SK-N-BE and SH-SY5Y neuroblastoma cell lines 116
Atypical chest pain: coronary or esophageal disease? 114
Challangers and Opportunities of Nanoparticle-Based Theranostics in Skin Cancer 114
Cholesteryl butyrate solid lipid nanoparticles inhibit adhesion of human neutrophils to endothelial cells 111
Intracellular accumulation and cytotoxicity of doxorubicin with different pharmaceutical formulations in human cancer cell lines 109
GSH-responsive nanoparticles in the treatment of tumor cells. 109
Oral bioavailability of Silymarin phytocomplex formulated as self-emulsifying pellets 108
Thiopurine S-methyltransferase pharmacogenetics on a large-scale healthy Italian caucasian population: difference in enzyme activity 107
Analgesic, Anti-inflammatory and gastric-damaging effects of dexibuptofen in rodents. 106
Ophthalmic delivery of dexamethasone and tobramycin incorporated in solid lipid nanoparticles 106
Impact of age in phenothype of thiopurine methyltransferase 105
Plasma immunoerythropoietin levels in patients with cancer receiving platin-based or 5-Fluorouracil-based chemotherapy 105
Motilin and erythromycin do not affect the motility of rat duodenum in vivo 105
Validation of a non-parametric approach to predict individual plasma concentrations from population data 105
Differences between Italian children and adults in thiopurine methyltransferase phenotype and genotype 103
SLN per la veicolazione di un analogo fluorescente della Ciclosporina A 103
Dexibuprofen (S(+)-isomer Ibuprofen) reduces gastric damage and improves analgesic and antiinflammatory effects in rodents 103
Simultaneous HPLC determination of 5-Fluorouracil and its metabolites in plasma of cancer patients 102
Thiopurine-methyl-transferase (TPMT) activity in inflammatory bowel disease (IBD) patients is not affected by co-administration of salycilates 102
Pharmacokinetics of cyclosporine in recipients of marginal versus standard liver transplants 101
Individualization of Ceftriaxone dosage through Bayesian inference on PK/PD population data 101
Methotrexate loaded SLN prepared by coacervation technique: in vitro cytotoxicity and in vivo pharmacokinetic and biodistribution 100
Determination of Ibuprofen in human plasma by high performance liquid chromatography: validation and application in pharmacokinetic study 99
Economic impact of resistance in the community. 97
[Anamnestic study of thoracic pain: comparison of angina and gastroesophageal reflux] 97
Single dose intramuscolar pharmacokinetics and local tolerability of three different disodium clodronate formulations in healthy volunteers 97
[Ambulatory digital manometry] 96
Plasma concentrations of 5-Fluorouracil and its metabolites in colon cancer patients 95
CYP3A and MDR1 (P-glycoprotein) gene expression levels along the human gastrointestinal tract 90
Prescriptive styles of general practitioner identified through Bayesian autoclassification method 90
Cholesteryl butyrate solid lipid nanoparticles inhibit adhesion of human neutrophils to endothelial cells 89
Pharmacokinetics of disodium clodronate after single intravenous or intramuscolar injection in healthy volunteers 88
Espression of CYP3A Isoforms and P-Glycoprotein in Human Stomach, Jejunum and Ileum 88
Lipid nanoparticles formed by solvent-in-water emulsion-diffusion technique: Development and influence on insulin stability 87
Dexibuprofen (S+-isomer ibuprofen) reduces gastric damage and improves analgesic and antiinflammatory effects in rodents. 86
Study of thiopurine-methyl-transferase (TPMT) genotype and phenotype in an Italian population 86
Phenotype and genotype between italian children and adults for thiopurine methyltransferase 85
Solid Lipid Nanoparticles carrying oligonucleotides inhibit Vascular Endothelial Grow Factor expression in rat glioma models 84
Mesalamine does not impact on thiopurine-methyl-transferase (TPMT) activity in inflammatory bowel disease (IBD) patients 84
Evaluation of antiproliferative activity of cholesteryl butyrate solid lipid nanospheres on leukemic cell lines 84
Long-term analgesic effect of clodronate in rodents 83
Effects of erythromycin on gastrointestinal tract motility. 82
[Long-term effects of gastric resection on the inferior esophageal sphincter] 81
[The lower esophageal sphincter in gastrectomized patients. Manometric study] 80
Duodenal administration of solid lipid nanoparticles loaded with different percentages of tobramycin 80
Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribution after i.v. administration to rats. 79
Genotype and phenotype analysis of thiopurine-methyl-transferase (TPMT) in a northern Italian population 78
Paclitaxel incorporato in nanoparticelle lipidiche solide: studio preliminare farmacocinetico e distribuzione cerebrale 76
Thiopurine S-Methyltransferase Pharmacogenetics on a Large-Scale Healthy Italian-Caucasian Population: Difference in Enzyme Activity among Infant, Children, Adolescent and Adult Subjects 75
Solid lipid nanoparticles in lymph and plasma after duodenal administration to rats. 73
High Energy Shock Waves (HESW) Increase Paclitaxel Efficacy in a Syngeneic Model of Breast Cancer 71
CYP3A and MDR1 (P-glycoprotein) gene expression levels along the human gastrointestinal tract 71
Expression of the Met/HGF receptor in normal and neoplastic human tissues 71
Pudendal neuropathy in diabetic patients with faecal incontinence. 71
Novel functionalized beta cyclodextrin nanosponge based stable formulation of camptothecin and in vitro cytotoxicity evaluation 70
Prevailingly cationic agmatine-based amphoteric polyamidoamine as a nontoxic, nonhemolytic, and stealthlike DNA complexing agent and transfection promoter 69
Cyclodextrin-based nanosponges encapsulating camptothecin: Physicochemical characterization, stability and cytotoxicity 68
Totale 12.517
Categoria #
all - tutte 41.642
article - articoli 0
book - libri 0
conference - conferenze 17.267
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.909


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021604 0 0 0 0 0 41 93 35 134 106 65 130
2021/20221.212 36 50 20 70 51 32 84 58 35 119 329 328
2022/20231.813 221 150 71 179 136 487 159 100 176 55 57 22
2023/2024738 106 138 63 27 65 133 20 24 8 19 40 95
2024/20252.127 28 98 58 204 593 112 55 105 284 104 144 342
2025/20262.239 512 219 477 510 498 23 0 0 0 0 0 0
Totale 13.824